Showing results (331-340 of 417) with videos related to

Sort By:
Pageof 42
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 26, 2022
Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosisJasmohan S Bajaj, K Rajender Reddy, Puneeta Tandon, et al.
Human Vaccines & Immunotherapeutics|March 3, 2023
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factorsLaura L Hammitt, Dean Quinn, Ewa Janczewska, et al.
Gut|July 15, 2020
Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohortJasmohan S Bajaj, Guadalupe Garcia-Tsao, Scott W Biggins, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2019
Early emergence of anti-HCV antibody implicates donor origin in recipients of an HCV-infected organPaige M Porrett, Peter P Reese, Vera Holzmayer, et al.
Plos One|August 2, 2018
A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational studyDonna M Evon, Paul W Stewart, Jipcy Amador, et al.
The American Journal of Gastroenterology|January 30, 2019
Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial PeritonitisJasmohan S Bajaj, Puneeta Tandon, Jacqueline G OʼLeary, et al.
Hepatology (Baltimore, Md.)|October 20, 2012
Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trialMark S Sulkowski, Fred Poordad, Michael P Manns, et al.
Hepatology (Baltimore, Md.)|April 17, 2020
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus StatementOren K Fix, Bilal Hameed, Robert J Fontana, et al.
The New England Journal of Medicine|March 3, 2021
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal SyndromeFlorence Wong, S Chris Pappas, Michael P Curry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 2, 2021
Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP studyMarina Serper, Donna M Evon, Jipcy Amador, et al.
Pageof 42